Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An image contrast agent selectively activated by prostate specific antigen.

Graham B Jones1, Curtis F Crasto, Jude E Mathews

  • 1Bioorganic and Medicinal Chemistry Laboratories, Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA. gr.jones@neu.edu

Bioorganic & Medicinal Chemistry
|September 28, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and racial predictors of adverse pathology at radical prostatectomy: implications for undertreatment among patients receiving radiation and hormonal therapy.

The Canadian journal of urology·2026
Same author

Postoperative Pelvic Lymph Node Radiation Therapy in Lymph Node-Positive Prostate Cancer and Mortality Risk.

European urology focus·2026
Same author

Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysis.

Cancer·2026
Same author

Surveillance Versus Treatment for Favorable Intermediate-Risk Prostate Cancer and Mortality-Risk.

The Prostate·2026
Same author

Cribriform-Positive and -Negative Prostate Cancer.

JAMA oncology·2026
Same author

FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide.

European urology·2026

Synthesized image contrast agents activate with enzymes like prostate specific antigen (PSA) and alpha-chymotrypsin. A specific derivative tracks PSA activity in vitro, offering a new diagnostic method.

Area of Science:

  • Bioconjugation Chemistry
  • Enzyme-triggered imaging agents

Background:

  • Development of targeted imaging agents is crucial for disease detection.
  • Enzymatic activation offers a pathway for specific in vivo or in vitro signal generation.

Purpose of the Study:

  • To synthesize novel image contrast agent conjugates.
  • To evaluate their activation by specific enzymes.
  • To develop a method for tracking prostate specific antigen (PSA) activity.

Main Methods:

  • Synthesis of a family of image contrast agent conjugates.
  • Enzymatic cleavage assays using prostate specific antigen (PSA) and alpha-chymotrypsin.
  • Characterization of released fluorophore upon enzymatic activation.

Main Results:

Related Experiment Videos

  • The synthesized agents were activated by both PSA and alpha-chymotrypsin.
  • Cleavage of a three-component system released free fluorophore.
  • A hexapeptide derivative demonstrated exclusive activation by PSA.

Conclusions:

  • A novel class of enzyme-activatable image contrast agents was successfully synthesized.
  • The agents show potential for enzymatic activity detection.
  • A PSA-specific derivative provides a method for in vitro PSA activity monitoring.